Cargando…
Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
SIMPLE SUMMARY: Both IAP and WEE1 inhibitors have demonstrated therapeutic efficacy in in vitro pre-clinical models of head and neck squamous cell carcinoma (HNSCC). Here, we demonstrate that dual treatment with IAP and WEE1 inhibitors sensitizes both HPV-negative and HPV-positive HNSCC cells to bot...
Autores principales: | Toni, Tiffany, Viswanathan, Ramya, Robbins, Yvette, Gunti, Sreenivasulu, Yang, Xinping, Huynh, Angel, Cheng, Hui, Sowers, Anastasia L., Mitchell, James B., Allen, Clint T., Morgan, Ethan L., Van Waes, Carter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954698/ https://www.ncbi.nlm.nih.gov/pubmed/36831373 http://dx.doi.org/10.3390/cancers15041029 |
Ejemplares similares
-
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
por: Morgan, Ethan L., et al.
Publicado: (2023) -
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
por: Ye, Wenda, et al.
Publicado: (2020) -
Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
por: Morgan, Ethan L., et al.
Publicado: (2020) -
Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells
por: Mitsuuchi, Y, et al.
Publicado: (2017) -
Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling
por: Condon, Stephen M
Publicado: (2016)